$2.82
+0.19 (+7.22%)
Open$2.67
Previous Close$2.63
Day High$3.10
Day Low$2.60
52W High$22.00
52W Low$1.70
Volume—
Avg Volume649.8K
Market Cap283.37M
P/E Ratio—
EPS$-1.14
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 755.1K | 122.20M | 119.09M |
| Net Income | -10,571,279 | 29.08M | 25.78M |
| Profit Margin | -1,392.6% | 23.8% | 21.7% |
| EBITDA | -6,685,528 | 41.35M | 38.15M |
| Free Cash Flow | — | 33.20M | 25.74M |
| Rev Growth | — | +2.9% | +5.6% |
| Debt/Equity | 0.01 | 0.45 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |